logo
  

Merck Q3 Results Top Estimates; Boosts FY21 Outlook - Quick Facts

Biopharmaceutical company Merck & Co., Inc. (MRK) reported Thursday that third-quarter net income attributable to the company increased to $4.57 billion or $1.80 per share from $2.32 billion or $0.92 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter was $1.75 per share, compared to $1.37 per share in the year-ago quarter.

On average, 13 analysts polled by Thomson Reuters expected the company to report earnings of $1.55 per share for the quarter. Analysts' estimates typically exclude special items.

Worldwide sales for the quarter increased 20 percent to $13.15 billion from $10.93 billion in the same quarter last year. The Street was looking for revenues of $12.33 billion for the quarter. Excluding the impact from foreign exchange, sales decreased 19 percent.

Pharmaceutical sales increased 8 percent to $11.50 billion, with KEYTRUDA sales growing 22 percent to $4.5 billion, GARDASIL / GARDASIL 9 surging 68 percent to $1.99 billion and JANUVIA / JANUMET sales edging up 1 percent to $1.34 billion from last year.

Merck said it is raising its outlook as it continues to experience strong global underlying demand across its business.

Looking ahead to fiscal 2021, Merck now projects earnings in a range of $4.71 to $4.76 per share and adjusted earnings in a range of $5.65 to $5.70 per share on sales growth of 14 to 15 percent and revenues between $47.4 billion and $47.9 billion, including a positive impact from foreign exchange of approximately 1.5 percent.

Previously, the company expected earnings in the range of $4.24 and $4.34 per share and adjusted earnings in the range of $5.47 and $5.57 per share on sales growth of 12 to 14 percent and revenues between $46.4 billion and $47.4 billion, including a positive impact from foreign exchange of less than 2 percent.

Analysts expect annual earnings of $5.77 per share on revenues of $48.16 billion for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Delivery services company DoorDash has introduced ultra-fast grocery deliveries with DashMart in Chelsea, New York City. The company said it aims to deliver in 10-15 minutes and plans to expand its new service in select DoorDash grocery and convenience partners over the next year. With over 2,000 items, DashMart offers a wide assortment of fresh and frozen grocery staples, snacks, household goods, and local products. Ontario, Canada-based Erie Meat Products Ltd. is recalling approximately 1,224 pounds of fully cooked chicken bologna products, according to the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS. The chicken bologna products were imported and distributed into the United States without the benefit of FSIS import reinspection. The U. S. Food and Drug Administration or FDA has issued a public health alert against Fulvic Care Powder and Tablets from Ontario, Canada -based Black Oxygen Organics due to elevated levels of lead and arsenic. The agency advised consumers not to use Fulvic Care Powder and Tablets from Black Oxygen or give the products to pets due to elevated levels of lead and arsenic.
Follow RTT